Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing.

CONCLUSION: ChRCC is a rare disease still not fully molecularly characterized. Next-generation sequencing analysis could be useful to identify potential mutation with prognostic value or that could be potential therapeutic targets.
PMID: 33556910 [PubMed - as supplied by publisher]

Source: Pathology, Research and Practice - February 1, 2021 Category: Pathology Authors: Mollica V, Franceschini T, Gruppioni E, Rizzo A, Ricci C, Schiavina R, Brunocilla E, Ardizzoni A, Fiorentino M, Giunchi F, Massari F Tags: Pathol Res Pract Source Type: research